Special Issue "The Diabetic Foot: Recent Advances and Future Developments"
Deadline for manuscript submissions: 15 November 2021.
Of all the diabetes complications that occur, foot ulceration is among the most debilitating and costly, with morbidity and mortality rates being worse than for many cancers. Nonetheless, research into diabetic foot ulcer prevention and management is making great strides.
Therefore, the editorial decision of Medicina to dedicate this Special Issue to the topic of diabetic foot complications could not be better timed or more fitting.
In this issue, we will discuss how innovative approaches and smart technologies may optimize the management and prevention of foot ulceration by identifying high-risk patients for timely interventions, personalizing foot ulcer offloading, and improving adherence to protective footwear. The advent of the COVID-19 pandemic has resulted in a paradigm shift in the delivery of care for those with diabetic foot ulcers. This has produced many challenges but also opportunities for the delivery of foot care. Thanks to advances in smartphones, mobile applications, smart wearables, and telemedicine, the “hospital- at-home” care delivery model has started to replace the traditional “face-to-face” clinical care approach.
In addition to advances in established treatment modalities, such as the management of infections and osteomyelitis, there has been a renaissance of local treatments including topical oxygen therapies. Furthermore, psychological stress and, in particular, depression have gained recognition as important determinants of foot ulcer development and impaired healing, while growing insights into the biomechanics of the diabetic foot have resulted in more effective foot ulcer prevention and treatment.
These are some of the many scientific developments in the field of the diabetic foot. We therefore encourage original publications that would further advance our medical knowledge of this all too common and devastating complication of diabetes.
Dr. Loretta Vileikyte
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- diabetic foot ulceration
- smart technologies
- topical treatments
- psychological stress
- ulcer offloading